Differential regulation of human CYP4A genes by peroxisome proliferators and dexamethasone.

[1]  J. Berger,et al.  Differential Gene Regulation in Human Versus Rodent Hepatocytes by Peroxisome Proliferator-activated Receptor (PPAR) α , 2001, The Journal of Biological Chemistry.

[2]  K. Griffin,et al.  Identification of Peroxisome Proliferator-responsive Human Genes by Elevated Expression of the Peroxisome Proliferator-activated Receptor α in HepG2 Cells* , 2001, The Journal of Biological Chemistry.

[3]  J. Falck,et al.  The CYP P450 arachidonic acid monooxygenases: from cell signaling to blood pressure regulation. , 2001, Biochemical and biophysical research communications.

[4]  M. Waterman,et al.  Alterations in the regulation of androgen-sensitive Cyp 4a monooxygenases cause hypertension , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[5]  R. Roman,et al.  Cytochrome P450 metabolites of arachidonic acid in the control of renal function , 2001, Current opinion in nephrology and hypertension.

[6]  C. Selden,et al.  Three Dimensional Culture Upregulates Extracellular Matrix Protein Expression in Human Liver Cell Lines - a Step towards Mimicking the Liver in Vivo? , 2000, The International journal of artificial organs.

[7]  J. McMillan,et al.  Expression of PPAR(alpha) in human hepatocytes and activation by trichloroacetate and dichloroacetate. , 2000, Research communications in molecular pathology and pharmacology.

[8]  K. Sugimura,et al.  Human fatty acid omega-hydroxylase, CYP4A11: determination of complete genomic sequence and characterization of purified recombinant protein. , 2000, Archives of biochemistry and biophysics.

[9]  L. Lash,et al.  Expression of glutathione-dependent enzymes and cytochrome P450s in freshly isolated and primary cultures of proximal tubular cells from human kidney. , 2000, The Journal of pharmacology and experimental therapeutics.

[10]  J. Falck,et al.  Cytochrome P450 and arachidonic acid bioactivation. Molecular and functional properties of the arachidonate monooxygenase. , 2000, Journal of lipid research.

[11]  W. Wahli,et al.  Peroxisome proliferator-activated receptors: nuclear control of metabolism. , 1999, Endocrine reviews.

[12]  J. Peters,et al.  Modulation of cytochrome P-450 gene expression in endotoxemic mice is tissue specific and peroxisome proliferator-activated receptor-alpha dependent. , 1999, The Journal of pharmacology and experimental therapeutics.

[13]  T. Pineau,et al.  Peroxisome Proliferator-activated Receptor α Controls the Hepatic CYP4A Induction Adaptive Response to Starvation and Diabetes* , 1998, The Journal of Biological Chemistry.

[14]  P. Veldhoven,et al.  Maturation of peroxisomes in differentiating human hepatoblastoma cells (HepG2) : possible involvement of the peroxisome proliferator-activated receptor α (PPARα) , 1998 .

[15]  A. Salter,et al.  Molecular basis of non-responsiveness to peroxisome proliferators: the guinea-pig PPARalpha is functional and mediates peroxisome proliferator-induced hypolipidaemia. , 1998, The Biochemical journal.

[16]  R. Roberts,et al.  A peroxisome proliferator-activated receptor-alpha (PPARα) cDNA cloned from guinea-pig liver encodes a protein with similar properties to the mouse PPARα: implications for species differences in responses to peroxisome proliferators , 1998, Archives of Toxicology.

[17]  P Fenner-Crisp,et al.  Do peroxisome proliferating compounds pose a hepatocarcinogenic hazard to humans? , 1998, Regulatory toxicology and pharmacology : RTP.

[18]  K. Griffin,et al.  Role of the peroxisome proliferator‐activated receptor in cytochrome P450 4A gene regulation , 1996, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[19]  D. Stroup,et al.  Hormonal regulation of the cholesterol 7 alpha-hydroxylase gene (CYP7). , 1995, Journal of lipid research.

[20]  K. Griffin,et al.  A single amino acid change in the mouse peroxisome proliferator-activated receptor alpha alters transcriptional responses to peroxisome proliferators. , 1995, Molecular pharmacology.

[21]  T. Pineau,et al.  Targeted disruption of the alpha isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators , 1995, Molecular and cellular biology.

[22]  S. Green,et al.  Identification and characterization of DNA elements implicated in the regulation of CYP4A1 transcription. , 1995, The Biochemical journal.

[23]  K. Gautvik,et al.  Dexamethasone and insulin demonstrate marked and opposite regulation of the steady-state mRNA level of the peroxisomal proliferator-activated receptor (PPAR) in hepatic cells. Hormonal modulation of fatty-acid-induced transcription. , 1994, European journal of biochemistry.

[24]  J. Auwerx,et al.  Regulation of the peroxisome proliferator-activated receptor alpha gene by glucocorticoids. , 1994, The Journal of biological chemistry.

[25]  S. Imaoka,et al.  Complete cDNA sequence and cDNA-directed expression of CYP4A11, a fatty acid omega-hydroxylase expressed in human kidney. , 1993, DNA and cell biology.

[26]  S. Imaoka,et al.  Changes in amounts of cytochrome P450 isozymes and levels of catalytic activities in hepatic and renal microsomes of rats with streptozocin-induced diabetes. , 1993, Biochemical pharmacology.

[27]  N. Jenkins,et al.  Species-specific induction of cytochrome P-450 4A RNAs: PCR cloning of partial guinea-pig, human and mouse CYP4A cDNAs. , 1993, The Biochemical journal.

[28]  T. Richardson,et al.  Characterization of a cDNA encoding a human kidney, cytochrome P-450 4A fatty acid omega-hydroxylase and the cognate enzyme expressed in Escherichia coli. , 1993, Biochimica et biophysica acta.

[29]  Eric F. Johnson,et al.  Rabbit Prostaglandin ω-Hydroxylase (CYP4A4): Gene Structure and Expression , 1993 .

[30]  A. Muerhoff,et al.  The peroxisome proliferator-activated receptor mediates the induction of CYP4A6, a cytochrome P450 fatty acid omega-hydroxylase, by clofibric acid. , 1992, The Journal of biological chemistry.

[31]  G. Gibson,et al.  Species differences in ciprofibrate induction of hepatic cytochrome P450 4A1 and peroxisome proliferation. , 1992, Journal of biochemical toxicology.

[32]  D. Jackson,et al.  The extracellular matrix coordinately modulates liver transcription factors and hepatocyte morphology , 1991, Molecular and cellular biology.

[33]  S. Imaoka,et al.  Changes in the amount of cytochrome P450s in rat hepatic microsomes with starvation. , 1990, Archives of biochemistry and biophysics.

[34]  O. Gotoh,et al.  cDNA cloning and inducible expression during pregnancy of the mRNA for rabbit pulmonary prostaglandin omega-hydroxylase (cytochrome P-450p-2). , 1987, The Journal of biological chemistry.

[35]  M. Rao,et al.  Identification of novel peroxisome proliferator-activated receptor alpha (PPARalpha) target genes in mouse liver using cDNA microarray analysis. , 2001, Gene expression.

[36]  K. Griffin,et al.  Peroxisome proliferator activated receptor-alpha expression in human liver. , 1998, Molecular pharmacology.